Have a personal or library account? Click to login
ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells Cover

ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells

Open Access
|May 2021

References

  1. Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S, Papaioannou A, Puschel F, Sassano ML, Skoko J, Agostinis P, de Belleroche J, Eriksson LA, Fulda S, Gorman AM, Healy S, Kozlov A, Munoz-Pinedo C, Rehm M, Chevet E, Samali A. Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J 286, 241–278, 2019.10.1111/febs.14608
  2. Arabanian LS, Johansson P, Staffas A, Nilsson T, Rouhi A, Fogelstrand L, Palmqvist L. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia. Leuk Res 75, 61–68, 2018.10.1016/j.leukres.2018.10.005
  3. Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proc Natl Acad Sci U S A 107, 15553–15558, 2010.10.1073/pnas.0914072107
  4. Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.10.1186/1471-2407-13-597
  5. Aversa CR, Oparil S, Caro J, Li H, Sun S-D, Chen Y-F, Swerdel MR, Monticello TM, Durham SK, Minchenko A, Lira SA, Webb ML. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. Amer J Physiol 273, L848–L855, 1997.10.1152/ajplung.1997.273.4.L848
  6. Aydin AF, Vural P, Dogru-Abbasoglu S, Cil E. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer. Mol Biol Rep 46, 199–205, 2019.10.1007/s11033-018-4461-8
  7. Bao N, Fang B, Lv H, Jiang Y, Chen F, Wang Z, Ma H. Upregulation of miR-199a-5p protects spinal cord against ischemia/reperfusion-induced injury via downregulation of ECE1 in rat. Cell Mol Neurobiol 38, 1293–1303, 2018.10.1007/s10571-018-0597-2
  8. Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Breuss J, Minchenko OH, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via induction of VEGF, IL-8, COX-2 and ADAMTS-1 metalloprotease, implicating a novel role for lipid oxidation in progression and destabilization of atherosclerotic lesions. Circ Res 99, 900–908, 2006.10.1161/01.RES.0000245485.04489.ee
  9. Boratko A, Vereb Z, Petrovski G, Csortos C. TIMAP-protein phosphatase 1-complex controls endothelin-1 production via ECE-1 dephosphorylation. Int J Biochem Cell Biol 73, 11–18, 2016.10.1016/j.biocel.2016.01.016
  10. Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E, Quest AF, Lavandero S. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 301, 215–290, 2013.10.1016/B978-0-12-407704-1.00005-1
  11. Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov 5, 586–597, 2015.10.1158/2159-8290.CD-14-1490
  12. Colombo SL, Palacios-Callender M, Frakich N, Carcamo S, Kovacs I, Tudzarova S, Moncada S. Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc Natl Acad Sci USA 108, 21069–21074, 2011.10.1073/pnas.1117500108
  13. Cook N, Brais R, Qian W, Hak CC, Corrie PG. Endothelin-1 and endothelin B receptor expression in pancreatic adenocarcinoma. J Clin Pathol 68, 309–313, 2015.10.1136/jclinpath-2014-202521
  14. Dashwood MR, Loesch A. Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects? J Cell Commun Signal 4, 51–62, 2009.10.1007/s12079-009-0073-3
  15. Dejeans N, Barroso K, Fernandez-Zapico ME, Samali A, Chevet E. Novel roles of the unfolded protein response in the control of tumor development and aggressiveness. Semin Cancer Biol 33, 67–73, 2015.10.1016/j.semcancer.2015.04.007
  16. Dojo Soeandy C, Salmasi F, Latif M, Elia AJ, Suo NJ, Henderson JT. Endothelin-1-mediated cerebral ischemia in mice: early cellular events and the role of caspase-3. Apoptosis 24, 578–595, 2019.10.1007/s10495-019-01541-z
  17. Doultsinos D, Avril T, Lhomond S, Dejeans N, Guedat P, Chevet E. Control of the unfolded protein response in health and disease. SLAS Discov 22, 787–800, 2017.10.1177/2472555217701685
  18. Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A, Moenner M. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res 67, 6700–6707, 2007.10.1158/0008-5472.CAN-06-3235
  19. Festuccia C, Biordi AL, Tombolini V, Hara A, Bailey D. Targeted molecular therapy in glioblastoma. J Oncology 2020, 5104876, 2020.10.1155/2020/5104876
  20. Fomin V, Richard P, Hoque M, Li C, Gu Z, Fissore-O’Leary M, Tian B, Prives C, Manley JL. The C9ORF72 gene, implicated in amyotrophic lateral sclerosis and frontotemporal dementia, encodes a protein that functions in control of endothelin and glutamate signaling. Mol Cell Biol 38, e00155–18, 2018.10.1128/MCB.00155-18
  21. He Y, Fan Q, Cai T, Huang W, Xie X, Wen Y, Shi Z. Molecular mechanisms of the action of Arctigenin in cancer. Biomed Pharmacother 108, 403–407, 2018.10.1016/j.biopha.2018.08.158
  22. Huber AL, Lebeau J, Guillaumot P, Petrilli V, Malek M, Chilloux J, Fauvet F, Payen L, Kfoury A, Renno T, Chevet E, Manie SN. p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression under low glucose. Mol Cell 49, 1049–1059, 2013.10.1016/j.molcel.2013.01.009
  23. Iurlaro R, Puschel F, Leon-Annicchiarico CL, O’Connor H, Martin SJ, Palou-Gramon D, Lucendo E, Munoz-Pinedo C. Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol Cell Biol 37, e00479-16, 2017.10.1128/MCB.00479-16
  24. Johnson GG, White MC, Grimaldi M. Stressed to death: targeting endoplasmic reticulum stress response induced apoptosis in gliomas. Curr Pharm Des 17, 284–292, 2011.10.2174/138161211795049660
  25. Khamaisi M, Toukan H, Axelrod JH, Rosenberger C, Skarzinski G, Shina A, Meidan R, Koesters R, Rosen S, Walkinshaw G, Mimura I, Nangaku M, Heyman SN. Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor. Kidney Int 87, 761–770, 2015.10.1038/ki.2014.362
  26. Khimji AK, Rockey DC. Endothelin—biology and disease. Cell. Signal 22, 1615–1625, 2010.10.1016/j.cellsig.2010.05.002
  27. Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jegou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauleon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 10, e7929, 2018.10.15252/emmm.201707929
  28. Liu K, Tsung K, Attenello FJ. Characterizing cell stress and GRP78 in glioma to enhance tumor treatment. Front Oncol 10, 608911, 2020.10.3389/fonc.2020.608911
  29. Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E, Dwyer RM, Oommen A, Legembre P, Godey F, Madden EC, Leuzzi B, Obacz J, Zeng Q, Patterson JB, Jager R, Gorman AM, Samali A. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 9, 3267, 2018.10.1038/s41467-018-05763-8
  30. Manie SN, Lebeau J, Chevet E. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update. Am J Physiol Cell Physiol 307, C901–C907, 2014.10.1152/ajpcell.00292.2014
  31. Marciniak SJ. Endoplasmic reticulum stress: a key player in human disease. FEBS J 286, 228–231, 2019.10.1111/febs.14740
  32. Markouli M, Strepkos D, Papavassiliou AG, Piperi C. Targeting of endoplasmic reticulum (ER) stress in gliomas. Pharmacol Res 157, 104823, 2020.10.1016/j.phrs.2020.104823
  33. Minchenko AG, Armstead VE, Opentanova IL, Lefer AM. Endothelin-1, endothelin receptors and ecNOS gene expression in vital organs during traumatic shock in rats. Endothelium 6, 303–314, 1999.10.3109/10623329909078497
  34. Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsible element. Mol Cell Biochem 208, 53–62, 2000.10.1023/A:1007042729486
  35. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose)polymerase activation. FASEB J 17, 1514–1516, 2003.10.1096/fj.03-0013fje
  36. Minchenko DO, Kharkova AP, Hubenia OV, Minchenko OH. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and gluta-mine or glucose deprivation. Endocr Reg 47, 15–26, 2013.10.4149/endo_2013_01_15
  37. Minchenko DO, Danilovskyi SV, Kryvdiuk IV, Bakalets TV, Lypova NM, Karbovskyi LL, Minchenko OH. Inhibition of ERN1 modifies the hypoxic regulation of the expression of TP53-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 1, 18–26, 2014.10.2478/ersc-2014-0001
  38. Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress. Endocr Reg 49, 73-83, 2015a.10.4149/endo_2015_02_73
  39. Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells. Endocr Reg 49, 185–197, 2015b.10.4149/endo_2015_04_185
  40. Minchenko DO, Tsymbal DO, Riabovol OO, Viletska YM, Lahanovska YO, Sliusar MY, Bezrodnyi BH, Minchenko OH. Hypoxic regulation of EDN1, EDNRA, EDNRB, and ECE1 gene expressions in IRE1 knockdown U87 glioma cells. Endocr Reg 53, 250–262, 2019.10.2478/enr-2019-0025
  41. Minchenko DO, Khita OO, Tsymbal DO, Danilovskyi SV, Rudnytska OV, Halkin OV, Kryvdiuk IV, Smeshkova MV, Yakymchuk MM, Bezrodnyi BH, Minchenko OH. Expression of IDE and PITRM1 genes in IRE1 knockdown U87 glioma cells: effect of hypoxia and glucose deprivation. Endocr Reg 54, 183–195, 2020a.10.2478/enr-2020-0021
  42. Minchenko OH, Tsymbal DO, Moenner M, Minchenko DO, Kovalevska OV, Lypova NM. Inhibition of the endoribonuclease of ERN1 signaling enzyme affects the expression of proliferation-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 2, 18–29, 2015c.10.1515/ersc-2015-0002
  43. Minchenko OH, Kryvdiuk IV, Minchenko DO, Riabovol OO, Halkin OV. Inhibition of IRE1 signaling affects expression of a subset genes encoding for TNF-related factors and receptors and modifies their hypoxic regulation in U87 glioma cells. Endoplasm Reticul Stress Dis 3, 1–15, 2016.10.1515/ersc-2016-0001
  44. Minchenko OH, Luzina OY, Hnatiuk OS, Minchenko DO, Garmash YA, Ratushna OO. Expression of tumor growth related genes in IRE1 knockdown U87 glioma cells: effect of hypoxia. Ukr Biochem J 89, 40–51, 2017.10.15407/ubj89.05.040
  45. Minchenko OH, Hnatiuk OS, Tsymbal DO, Viletska YM, Danilovskyi SV, Halkin OV, Kryvdiuk IV, Rudnytska OV. ERN1 depended regulation of TMED10, MYL9, SPOCK1, CUL4A and CUL4B gene expressions by glucose and glutamine deprivations in U87 glioma cells. Ukr Biochim J 92, 50–61, 2020b.10.15407/ubj92.05.050
  46. Miners JS, Love S. Endothelin-converting enzymes degrade alpha-synuclein and are reduced in dementia with Lewy bodies. J Neurochem 141, 275–286, 2017.10.1111/jnc.13974
  47. Nayak L, Reardon DA. High-grade Gliomas. Continuum (Minneap Minn) 23, 1548–1563, 2017.10.1212/CON.0000000000000554
  48. Niechi I, Silva E, Cabello P, Huerta H, Carrasco V, Villar P, Cataldo LR, Marcelain K, Armisen R, Varas-Godoy M, Fernandez C, Tapia JC. Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability. Oncotarget 6, 42749–42760, 2015.10.18632/oncotarget.5722
  49. Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, Chevet E. Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives. Sci Signal 10, eaal2323, 2017.10.1126/scisignal.aal2323
  50. Obiedat A, Seidel E, Mahameed M, Berhani O, Tsukerman P, Voutetakis K, Chatziioannou A, McMahon M, Avril T, Chevet E, Mandelboim O, Tirosh B. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/ XBP1 pathway of the unfolded protein response through the regulation of E2F1. FASEB J 33, 3481–3495, 2019.10.1096/fj.201801350RR
  51. Palmer JC, Barker R, Kehoe PG, Love S. Endothelin-1 is elevated in Alzheimer’s disease and upregulated by amyloid-β. J Alzheimers Dis 29, 853–861, 2012.10.3233/JAD-2012-111760
  52. Papaioannou A, Chevet E. Driving cancer tumorigenesis and metastasis through UPR signaling. Curr Top Microbiol Immunol 414, 159–192, 2018.10.1007/82_2017_36
  53. Parzych K, Saavedra-Garcia P, Valbuena GN, Al-Sadah HA, Robinson ME, Penfold L, Kuzeva DM, Ruiz-Tellez A, Loaiza S, Holzmann V, Caputo V, Johnson DC, Kaiser MF, Karadimitris A, Lam EW, Chevet E, Feldhahn N, Keun HC, Auner HW. The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation. Oncogene 38, 3216–3231, 2019.10.1038/s41388-018-0651-z
  54. Pulido I, Ollosi S, Aparisi S, Becker JH, Aliena-Valero A, Benet M, Rodriguez ML, Lopez A, Tamayo-Torres E, Chulia-Peris L, Garcia-Canaveras JC, Soucheray M, Dalheim AV, Salom JB, Qiu W, Kaja S, Fernandez-Coronado JA, Alandes S, Alcacer J, Al-Shahrour F, Borgia JA, Juan O, Nishimura MI, Lahoz A, Carretero J, Shimamura T. Endothelin-1-mediated drug resistance in EGFR-mutant non-small cell lung carcinoma. Cancer Res 80, 4224–4232, 2020.10.1158/0008-5472.CAN-20-0141
  55. Ratushna OO. Glucose deprivation affects the expression of genes encoding cAMP-activated protein kinase and related proteins in U87 glioma cells in ERN1 dependent manner. Endocr Reg 54, 244–254, 2020.10.2478/enr-2020-0027
  56. Riabovol OO, Tsymbal DO, Minchenko DO, Lebid-Biletska KM, Sliusar MY, Rudnytska OV, Minchenko OH. Effect of glucose deprivation on the expression of genes encoding glucocorticoid receptor and some related factors in ERN1-knockdown U87 glioma cells. Endocr Reg 53, 237–249, 2019.10.2478/enr-2019-0024
  57. Rosano L, Cianfrocca R, Sestito R, Tocci P, Di Castro V, Bagnato A. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer. Expert Opin Ther Targets 21, 925–932, 2017.10.1080/14728222.2017.1361930
  58. Rudnytska OV, Khita OO, Minchenko DO, Tsymbal DO, Yefimova YV, Sliusar MY, Minchenko OH. The low doses of SWCNTs exhibit a genotoxic effect on the normal human astrocytes by disrupting the functional integrity of the genome. Currr Res Toxicol 2, 64–71, 2021.10.1016/j.crtox.2021.02.001
  59. Russignan A, Spina C, Tamassia N, Cassaro A, Rigo A, Bagnato A, Rosano L, Bonalumi A, Gottardi M, Zanatta L, Giacomazzi A, Scupoli MT, Tinelli M, Salvadori U, Mosna F, Zamo A, Cassatella MA, Vinante F, Tecchio C. Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. Br J Haematol 178, 781–793, 2017.10.1111/bjh.14771
  60. Stow LR, Jacobs ME, Wingo CS, Cain BD. Endothelin-1 gene regulation. FASEB J 25, 16–28, 2011.10.1096/fj.10-161612
  61. Tapia JC, Niechi I. Endothelin-converting enzyme-1 in cancer aggressiveness. Cancer Lett 452, 152–157, 2019.10.1016/j.canlet.2019.03.033
  62. Teramoto K, Katoh H. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions. Cell Signal 62, 109329, 2019.10.1016/j.cellsig.2019.05.014
  63. Teoh JP, Park KM, Wang Y, Hu Q, Kim S, Wu G, Huang S, Maihle N, Kim IM. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Cell Signal 26, 2885–2895, 2014.10.1016/j.cellsig.2014.08.024
  64. Tsymbal DO, Minchenko DO, Khita OO, Rudnytska OV, Viletska YM, Lahanovska YO, He Q, Liu K, Minchenko OH. ERN1 knockdown modifies the effect of glucose deprivation on homeobox gene expressions in U87 glioma cells. Endocr Reg 54, 196–206, 2020.10.2478/enr-2020-0022
  65. Yang J, Shi Z, Liu R, Wu Y, Zhang X. Combined-therapeutic strategies synergistically potentiate glioblastoma multi-forme treatment via nanotechnology. Theranostics 10, 3223–3239, 2020.10.7150/thno.40298
  66. Zhang J, Zhao WS, Wang X, Xu L, Yang XC. Palmitic acid increases endothelin-1 expression in vascular endothelial cells through the induction of endoplasmic reticulum stress and protein kinase C signaling. Cardiology 140, 133–140, 2018.10.1159/000490093
  67. Zhang L, Luo B, Dang YW, He RQ, Chen G, Peng ZG, Feng ZB. The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism. Exp Mol Pathol 107, 141–157, 2019.10.1016/j.yexmp.2019.02.002
  68. Zhao S, Cai J, Li J, Bao G, Li D, Li Y, Zhai X, Jiang C, Fan L. Bioinformatic profiling identifies a glucose-related risk signature for the malignancy of glioma and the survival of patients. Mol Neurobiol 54, 8203–8210, 2017.10.1007/s12035-016-0314-4
DOI: https://doi.org/10.2478/enr-2021-0009 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 72 - 82
Published on: May 21, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Dmytro O. Minchenko, Olena O. Khita, Dariia O. Tsymbal, Yuliia M. Viletska, Myroslava Y. Sliusar, Yuliia V. Yefimova, Liudmyla O. Levadna, Dariia A. Krasnytska, Oleksandr H. Minchenko, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.